Literature DB >> 22851717

Simple adaptations to the Templeton model for IVF outcome prediction make it current and clinically useful.

P Arvis1, P Lehert, A Guivarc'h-Levêque.   

Abstract

STUDY QUESTION: What is the validity of the Templeton model (TM) in predicting live birth (LB) for a couple starting an IVF/ICSI cycle? SUMMARY ANSWER: A centre-specific model based on the original predictors of the TM may reach a sufficient level of accuracy to be used in every day practice, with a few simple adaptations. WHAT IS KNOWN AND WHAT THIS PAPER ADDS: The TM seems the best predictive model of LB in IVF. However, previous validations of the TM suggest a lack of discrimination and calibration which means that it is not used in regular practice. We confirm this finding, and argue that such results are predictable, and essentially due to a strong centre effect. We provide evidence that the TM constitutes a useful reference reflecting a high proportion of the patient-mix effect since the parameters of the model remain invariant among centres, but also across various cultures, countries and types of hospitals. The only difference was the intercept value, interpreted as the measurement of the global performance of one centre, in particular, for a population of reference. STUDY
DESIGN: The validity of the TM was tested by a retrospective analysis all IVF/ICSI cycles (n = 12 901) in our centre since 2000. PARTICIPANTS, SETTING AND METHODS: All IVF/ICSI cycles were included in the analysis. The model discrimination was evaluated by C-statistics, calculated as the area under the curve of an ROC curve. The TM was then adjusted for our data and additional variables were assessed. MAIN RESULTS AND THE ROLE OF CHANCE: Poor calibration and discrimination (C = 0.64) was observed in conformity with previous external validations. Fitting the TM to our centre constituted the first substantial improvement in prediction accuracy of discrimination (C = 0.69) and calibration. We identified an important linear time trend effect and the added value of three other predictors (FSH, smoking habits and BMI) that significantly improved the model (C = 0.71). BIAS, CONFOUNDING AND OTHER REASONS FOR CAUTION: Bias due to missing data handling was assessed through sensitivity analyses. GENERALIZABILITY TO OTHER POPULATIONS: Neither the TM nor any other models based on some centres are directly applicable to other centres. However, the TM constitutes a useful basis to build an accurate centre-specific model. STUDY FUNDING/COMPETING INTEREST(S): There were no commercial relationships (i.e. consultancies, patent-licensing agreements) that might pose a conflict of interest in connection with the submitted manuscript. The objective of this research was not directed toward any treatment effects.

Entities:  

Mesh:

Year:  2012        PMID: 22851717     DOI: 10.1093/humrep/des283

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  7 in total

1.  To what extent does Anti-Mullerian Hormone contribute to a better prediction of live birth after IVF?

Authors:  Catherine Rongieres; Carolina Colella; Philippe Lehert
Journal:  J Assist Reprod Genet       Date:  2014-11-05       Impact factor: 3.412

2.  Can Ratios Between Prognostic Factors Predict the Clinical Pregnancy Rate in an IVF/ICSI Program with a GnRH Agonist-FSH/hMG Protocol? An Assessment of 2421 Embryo Transfers, and a Review of the Literature.

Authors:  Philippe Merviel; Michel Menard; Rosalie Cabry; Florence Scheffler; Emmanuelle Lourdel; Marie-Thérèse Le Martelot; Sylvie Roche; Jean-Jacques Chabaud; Henri Copin; Hortense Drapier; Moncef Benkhalifa; Damien Beauvillard
Journal:  Reprod Sci       Date:  2020-09-04       Impact factor: 3.060

3.  Fertility technologies and how to optimize laboratory performance to support the shortening of time to birth of a healthy singleton: a Delphi consensus.

Authors:  Giovanni Coticchio; Barry Behr; Alison Campbell; Marcos Meseguer; Dean E Morbeck; Valerio Pisaturo; Carlos E Plancha; Denny Sakkas; Yanwen Xu; Thomas D'Hooghe; Evelyn Cottell; Kersti Lundin
Journal:  J Assist Reprod Genet       Date:  2021-02-18       Impact factor: 3.412

4.  External validation and calibration of IVFpredict: a national prospective cohort study of 130,960 in vitro fertilisation cycles.

Authors:  Andrew D A C Smith; Kate Tilling; Debbie A Lawlor; Scott M Nelson
Journal:  PLoS One       Date:  2015-04-08       Impact factor: 3.240

5.  Predicting the chance on live birth per cycle at each step of the IVF journey: external validation and update of the van Loendersloot multivariable prognostic model.

Authors:  Johanna Devroe; Karen Peeraer; Geert Verbeke; Carl Spiessens; Joris Vriens; Eline Dancet
Journal:  BMJ Open       Date:  2020-10-08       Impact factor: 2.692

6.  Adaptive data-driven models to best predict the likelihood of live birth as the IVF cycle moves on and for each embryo transfer.

Authors:  Véronika Grzegorczyk-Martin; Julie Roset; Pierre Di Pizio; Thomas Fréour; Paul Barrière; Jean Luc Pouly; Michael Grynberg; Isabelle Parneix; Catherine Avril; Joe Pacheco; Tomasz M Grzegorczyk
Journal:  J Assist Reprod Genet       Date:  2022-06-29       Impact factor: 3.357

7.  Predicting live birth chances for women with multiple consecutive failing IVF cycles: a simple and accurate prediction for routine medical practice.

Authors:  Géraldine Porcu; Philippe Lehert; Carolina Colella; Claude Giorgetti
Journal:  Reprod Biol Endocrinol       Date:  2013-01-09       Impact factor: 5.211

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.